Robert A. Copeland, EVP and CSO at Epizyme, Inc. (EPZM), sold 20,000 shares at $27.74 ($538K) on 2014-10-07, disclosed to the SEC on 2014-10-09.
Scheduled sale ($538k) by EVP and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.86 | 19,000 | $510K | 94.8% |
| 2 | $27.74 | 1,000 | $28K | 5.2% |
| Total | $26.90 avg | 20,000 | $538K | 100% |
| Filing → |
| EPZM | SELL | 2017-04-05 | $41K | — | Filing → |
| EPZM | SELL | 2016-08-03 | $83K | — | Filing → |
| EPZM | SELL | 2016-07-07 | $80K | — | Filing → |